These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 31985852

  • 1. Interlaboratory analysis of teicoplanin plasma concentration assays among Chinese laboratories.
    Wang XX, Jin PF, Li PM, Xu S, Kong XD, Qin W, Chen WQ, Qin WJ, Zhang XL.
    J Clin Pharm Ther; 2020 Oct; 45(5):983-990. PubMed ID: 31985852
    [Abstract] [Full Text] [Related]

  • 2. Measurement of Teicoplanin Concentration With Liquid Chromatography-Tandem Mass Spectrometry Method Demonstrates the Usefulness of Therapeutic Drug Monitoring in Hematologic Patient Populations.
    Chae H, Lee JJ, Cha K, Her SH, Kim HY, Han E, Kim M, Kim Y, Cho SY, Lee DG.
    Ther Drug Monit; 2018 Jun; 40(3):330-336. PubMed ID: 29746433
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic drug monitoring of teicoplanin using an LC-MS/MS method: Analysis of 421 measurements in a naturalistic clinical setting.
    Jung J, Lee K, Oh J, Choi R, Woo HI, Park HD, Kang CI, Kim YJ, Lee SY.
    J Pharm Biomed Anal; 2019 Apr 15; 167():161-165. PubMed ID: 30776754
    [Abstract] [Full Text] [Related]

  • 4. Development and Validation of a High-Performance Liquid Chromatography With Ultraviolet Detection Method to Facilitate Therapeutic Monitoring of Teicoplanin Using Dried Blood Spots.
    Ramadan O, Opitz P, Hempel G.
    Ther Drug Monit; 2024 Oct 01; 46(5):627-633. PubMed ID: 38917389
    [Abstract] [Full Text] [Related]

  • 5. The quality of clinical serum teicoplanin assays: an experimental European EQA distribution.
    White LO, McMullin C, Davis AJ, MacGowan AP, Harding I, Reeves DS.
    J Antimicrob Chemother; 1996 Oct 01; 38(4):701-6. PubMed ID: 8937964
    [Abstract] [Full Text] [Related]

  • 6. An assessment of teicoplanin use and monitoring serum levels in a Chinese teaching hospital.
    Dong YL, Dong HY, Hu SS, Wang X, Wei YX, Wang MY, Dong WH, Yao HP, You HS, Xing JF.
    Int J Clin Pharmacol Ther; 2011 Jan 01; 49(1):14-22. PubMed ID: 21176720
    [Abstract] [Full Text] [Related]

  • 7. Factors on trough teicoplanin levels, associations between levels, efficacy and safety in patients with gram-positive infections.
    Wang T, Li N, Hu S, Xie J, Lei J, Wang Y, Zheng X, Xing J, Dong Y.
    Int J Clin Pharmacol Ther; 2015 May 01; 53(5):356-62. PubMed ID: 25828639
    [Abstract] [Full Text] [Related]

  • 8. Integrated identification-quantification (ID-Quant) workflow utilizing UPLC-QTOF-MS for the therapeutic drug monitoring of multi-component antibiotics without pure standards: Validation using teicoplanin.
    Ma X, Zou Y, Zhong J, Yu S, Qiu L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jun 01; 1240():124132. PubMed ID: 38714089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
    Tsai IL, Sun HY, Chen GY, Lin SW, Kuo CH.
    Talanta; 2013 Nov 15; 116():593-603. PubMed ID: 24148450
    [Abstract] [Full Text] [Related]

  • 11. Evaluating the optimal dose of teicoplanin with therapeutic drug monitoring: not too high for adverse event, not too low for treatment efficacy.
    Kim SH, Kang CI, Huh K, Cho SY, Chung DR, Lee SY, Kim YJ, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2019 Nov 15; 38(11):2113-2120. PubMed ID: 31372903
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A simplified chart for determining the initial loading dose of teicoplanin in critically ill patients.
    Yoshida S, Suzuki A, Ohmori T, Niwa T, Okada H, Suzuki K, Kobayashi R, Doi T, Kitaichi K, Matsuura K, Murakami N, Ogura S, Itoh Y.
    Pharmazie; 2017 Jan 10; 72(1):53-57. PubMed ID: 29441898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loading dose required to achieve rapid therapeutic teicoplanin trough plasma concentration in patients with multidrug-resistant gram-positive infections.
    Wang JT, Liao HI, Wu Lin FL, Chang SC.
    Basic Clin Pharmacol Toxicol; 2012 May 10; 110(5):416-20. PubMed ID: 22309355
    [Abstract] [Full Text] [Related]

  • 18. The use and therapeutic drug monitoring of teicoplanin in the UK.
    Darley ES, MacGowan AP.
    Clin Microbiol Infect; 2004 Jan 10; 10(1):62-9. PubMed ID: 14706088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples.
    Ferrari D, Ripa M, Premaschi S, Banfi G, Castagna A, Locatelli M.
    J Pharm Biomed Anal; 2019 May 30; 169():11-18. PubMed ID: 30826487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.